Sensex reclaims 44,000 on opening amid COVID-19 vaccine hopes; RIL shares lead pack

By: |
November 23, 2020 11:01 AM

Indian shares rose on Monday as hopes for imminent coronavirus vaccines helped boost global investor sentiment, while RIL led gains domestically after winning regulatory approval for a $3.4 billion deal.

Sensex, NiftyReliance Industries advanced 3% after the country's competition watchdog approved its deal to buy Future Group's retail assets

Indian shares rose on Monday as hopes for imminent coronavirus vaccines helped boost global investor sentiment, while Reliance Industries led gains domestically after winning regulatory approval for a $3.4 billion deal. The NSE Nifty 50 index was up 0.49% at 12,929.15. The S&P BSE Sensex climbed 0.51% to 44,105.39.

The first COVID-19 vaccines could be given to U.S. healthcare workers and others recommended by mid-December, a top health official said on Sunday, helping Asian stock markets trade higher on Monday. In India, Reliance Industries advanced 3% after the country’s competition watchdog approved its deal to buy Future Group’s retail assets.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Best blue chip stocks to buy for long-term; check how to track multibagger stocks
2Titan Company Rating: Hold – Strong performance in Q4FY21
3Kotak Mahindra Bank Rating: Reduce- Treasury gains offset impact of provisions